Clinical Blogs

The U.S. Food and Drug Administration (FDA) recently released a MedWatch Safety Alert regarding serious concerns around the use of gabapentinoids and the risk of serious breathing problems for patients who have respiratory risk factors, as well as those utilizing opioids or any other medications...

The long and winding road for the drug Embeda® (morphine sulfate and naltrexone hydrochloride) appears to be nearing its end. The manufacturer, Pfizer, has not yet released any public information, but the Food and Drug Administration (FDA) has posted on its website the date of November 15, 2019,...

The Centers for Disease Control and Prevention (CDC) was the first to sound the alarm on the U.S. opioid epidemic. For years, the CDC tracked the epidemic and shared the alarming statistics with the medical community in hopes that it would make an impact, yet opioid overdose deaths continued to rise....

Lyrica was initially approved by the FDA in 2004. Following approval for further indications in 2007 and again in 2012, Lyrica’s patent was finally set to expire at the end of 2018. Since Lyrica is routinely seen as one of the higher spend medications in Workers’...

On April 19, the Food and Drug Administration (FDA) granted final approval of the first generic for naloxone nasal spray, more commonly known as Narcan. Naloxone is an opioid antagonist and this life-saving medication can stop or reverse the effects of an opioid overdose.“In the wake of the opioid...

Hepatitis C, a viral infection of the liver caused by the hepatitis C virus (HCV), can be spread through contaminated blood and other body fluids. The infection can range in duration from a few weeks (acute) to a life-long illness (chronic). Between 75% and 85% of the people who become infected with...

The U.S Food and Drug Administration (FDA) recently reviewed two new opioid medications for approval – Dsuvia® and Olinvo®. The crisis of opioid addiction is a great concern in our country. The FDA is taking steps to actively confront this crisis, while also keeping the needs of the patients and...

Like all drugs, opioids can cause side effects. However, beyond the commonly reported effects such as nausea, constipation, dizziness and sedation, there is one side effect that presents the biggest obstacle to the usefulness of opioids: euphoria. Euphoria is a feeling of pleasure, excitement, well-being...

On February 5, the Annals of Internal Medicine published results from a study that aimed to determine the efficacy of compounded creams utilized for chronic pain. Researchers from Walter Reed National Military Medical Center separated 399 patients into groups of those experiencing neuropathic pain,...

Why take two pills when you only have to take one? That was the philosophy of Horizon Pharma in developing Duexis®...